Iliopsoas Nerve Block and Femoral Nerve Block in Hip Fracture Surgeries

Ain Shams University

Status: Enrolling

Conditions: Femoral Nerve Block; Hip Fracture Surgeries; Iliopsoas Nerve Block

Treatments: Drug: Iliopsoas nerve block; Drug: Femoral nerve block

Study type: Observational

Funder types: Other

Identifiers

NCT06852378

FMASU MD38/2025

Details and patient eligibility

About

This study aims to compare iliopsoas nerve Block (IPB) to femoral nerve block (FNB) regarding pain control, patient satisfaction, and early ambulation in patients undergoing hip fracture surgeries

Full description

Hip fractures are among the most frequent fractures seen in the emergency department and orthopedic trauma teams. The terms hip fracture and neck of femur fracture are used synonymously. Both terms describe a proximal femur fracture between the femoral head and 5 cm distal to the lesser trochanter.

Iliopsoas nerve Block (IPB) is a promising motor-sparing analgesic technique that selectively targets the sensory branches of the hip joint originating from the femoral nerve and accessory obturator nerve, sparing the motor supply of quadriceps muscles.

A femoral nerve block (FNB) is a simple nerve block that can be performed easily without or under ultrasound guidance. Under ultrasound guidance, the femoral artery and femoral nerve were identified clearly, and a needle was inserted using an in-plane approach from the lateral to the medial direction. Once the needle tip's position was confirmed, 10 ml of 0.5% bupivacaine was injected adjacent to the femoral nerve.

Enrollment: 80 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age from 18 to 65 years.
• Both sexes.
• American Society of Anesthesiologists (ASA) physical status I and II.
• Patients who are scheduled for elective surgical correction of hip fracture either through open fracture internal fixation (ORIF), partial hip arthroplasty or total hip arthroplasty.

Exclusion criteria

• Refusal to participate.
• Coagulopathy.
• Patients with a history of drug allergies to study drugs.
• Inability to cooperate.

Trial design

80 participants in 2 patient groups

Iliopsoas nerve block group

Description:

Patients will receive an Iliopsoas nerve block using 10 ml of bupivacaine 0.5%.

Treatment:

Drug: Iliopsoas nerve block

Femoral nerve block group

Description:

Patients will receive femoral nerve block using 10 ml of bupivacaine 0.5%.

Treatment:

Drug: Femoral nerve block